Avalon Trust’s Transmedics TMDX Stock Holding History

Avalon Trust’s Portfolio TMDX Stock Details TMDX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$7.46K	Hold	75	–	–	﹤0.01%	413
2025 Q4	$9.12K	Buy	+75	New	+$9.41K	﹤0.01%	381

Other funds holding TMDX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

NAMI

Nomura Asset Management International Philadelphia, Pennsylvania $58.4B AUM

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Avalon Trust's TMDX Position: Q1 2026 in Review

Avalon Trust held its Transmedics (TMDX) position steady in Q1 2026 at 75 shares worth $7.46K. The position accounts for ﹤0.01% of the portfolio, ranked #413.

Avalon Trust first reported a position in TMDX in Q4 2025 and has held it in 2 quarters since. The position peaked at $9.12K in Q4 2025. 414 funds tracked by Wall St. Rank hold TMDX as of Q1 2026.

Avalon Trust held 75 shares of Transmedics worth $7.46K as of Q1 2026.
Avalon Trust left its Transmedics share count unchanged in Q1 2026.
Transmedics made up ﹤0.01% of Avalon Trust's portfolio in Q1 2026, its #413 holding.
Avalon Trust first reported a position in Transmedics in Q4 2025 and has held it in 2 quarters since.
Avalon Trust's Transmedics position peaked at $9.12K in Q4 2025.
414 funds tracked by Wall St. Rank held Transmedics as of Q1 2026.

Based on Avalon Trust's 13F filing for Q1 2026, filed 6 May 2026.